-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HrM9GHaRBewmcOzzsQ14epj2B8xodHzAu9TIH6tMXN9bot2IYNeNwsbsI9Sb/5RA cT/EGjbjAf3pmR/CbZMgyg== 0001209191-05-027489.txt : 20050520 0001209191-05-027489.hdr.sgml : 20050520 20050520184918 ACCESSION NUMBER: 0001209191-05-027489 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050519 FILED AS OF DATE: 20050520 DATE AS OF CHANGE: 20050520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ENGBERS WILLIAM CENTRAL INDEX KEY: 0001234363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 05849448 BUSINESS ADDRESS: STREET 1: C/O LA JOLLA PHARMACEUTICAL CO STREET 2: 6455 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8586466649 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-05-19 1 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001234363 ENGBERS WILLIAM 6455 NANCY RIDGE DRIVE SAN DIEGO CA 92121 1 0 0 0 Stock Options (right to buy) 3.625 2005-05-19 4 D 0 20000 0.00 D 2007-05-19 Common Stock 20000 128795 D Stock Options (right to buy) 3.625 2005-05-19 4 A 0 20000 0.00 A 2008-12-03 Common Stock 20000 148795 D Stock Options (right to buy) 0.484 2005-05-19 4 D 0 41143 0.00 D 2007-05-19 Common Stock 41143 107652 D Stock Options (right to buy) 0.484 2005-05-19 4 A 0 41143 0.00 A 2009-09-28 Common Stock 41143 148795 D Stock Options (right to buy) 0.344 2005-05-19 4 D 0 4011 0.00 D 2007-05-19 Common Stock 4011 144784 D Stock Options (right to buy) 0.344 2005-05-19 4 A 0 4011 0.00 A 2009-11-02 Common Stock 4011 148795 D Stock Options (right to buy) 3.688 2005-05-19 4 D 0 10846 0.00 D 2007-05-19 Common Stock 10846 137949 D Stock Options (right to buy) 3.688 2005-05-19 4 A 0 10846 0.00 A 2010-01-28 Common Stock 10846 148795 D Stock Options (right to buy) 2.97 2005-05-19 4 D 0 5000 0.00 D 2007-05-19 Common Stock 5000 143795 D Stock Options (right to buy) 2.97 2005-05-19 4 A 0 5000 0.00 A 2013-05-12 Common Stock 5000 148795 D Stock Options (right to buy) 4.71 2005-05-19 4 D 0 5000 0.00 D 2007-05-19 Common Stock 5000 143795 D Stock Options (right to buy) 4.71 2005-05-19 4 A 0 5000 0.00 A 2013-09-18 Common Stock 5000 148795 D Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 12/03/1998. Options were fully vested on 12/03/2000. Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 09/28/1999. Options were fully vested on 12/28/2000. Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 11/02/1999. Options were fully vested on 12/02/2000. Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 01/28/2000. Options were fully vested on 12/28/2000. Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 05/12/2003. On 5/19/2005, 3,333 options were vested. Mr. Engbers ceased being a director of the Company on 05/19/2005. Immediately prior to his cessation of service as a director the vesting period was accelerated so that all options were fully vested on 5/19/2005. Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 09/18/2003. On 5/19/2005, 2,778 options were vested. Mr. Engbers ceased being a director of the Company on 05/19/2005. Immediately prior to his cessation of service as a director the vesting period was accelerated so that all options were fully vested on 5/19/2005. /s/ Gail A. Sloan Attorney-in-fact for William E. Engbers 2005-05-20 EX-24.4_86531 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Steven B. Engle and Gail A. Sloan signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or ten percent stockholder of La Jolla Pharmaceutical Company (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of February 13, 2002. Signature: /s/ William E. Engbers Print Name: William E. Engbers -----END PRIVACY-ENHANCED MESSAGE-----